Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Croft

Showing results (261-270 of 356) with videos related to

Pageof 36
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activityGunther Bal, Pieter Van der Veken, Dimitri Antonov, et al.
Plos Neglected Tropical Diseases|February 3, 2021
Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, IndiaNatalie J Dial, Graham F Medley, Simon L Croft, et al.
International Journal of Epidemiology|September 28, 2010
Cohort Profile: Pathways of risk from conception to disease: the Western Australian schizophrenia high-risk e-CohortVera A Morgan, Giulietta M Valuri, Maxine L Croft, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2007
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivoL Vivas, L Rattray, L B Stewart, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 20, 2004
Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometricsNigel J C Bailey, Yulan Wang, Julia Sampson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 14, 2012
Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depressionVera A Morgan, Maxine L Croft, Giulietta M Valuri, et al.
Journal of Inorganic Biochemistry|June 24, 2003
Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparumNikhil H Gokhale, Subhash B Padhye, Simon L Croft, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin BGert-Jan Wijnant, Katrien Van Bocxlaer, Amanda Fortes Francisco, et al.
International Journal of Antimicrobial Agents|May 30, 2017
Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasisHollie Burrell-Saward, Andrew J Harris, Raul de LaFlor, et al.
Pain|May 17, 2003
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle painLois J Kehl, Darryl T Hamamoto, Paul W Wacnik, et al.
Pageof 36

Showing results (261-270 of 356) with videos related to

Sort By:
Pageof 36
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activityGunther Bal, Pieter Van der Veken, Dimitri Antonov, et al.
Plos Neglected Tropical Diseases|February 3, 2021
Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, IndiaNatalie J Dial, Graham F Medley, Simon L Croft, et al.
International Journal of Epidemiology|September 28, 2010
Cohort Profile: Pathways of risk from conception to disease: the Western Australian schizophrenia high-risk e-CohortVera A Morgan, Giulietta M Valuri, Maxine L Croft, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2007
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivoL Vivas, L Rattray, L B Stewart, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 20, 2004
Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometricsNigel J C Bailey, Yulan Wang, Julia Sampson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 14, 2012
Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depressionVera A Morgan, Maxine L Croft, Giulietta M Valuri, et al.
Journal of Inorganic Biochemistry|June 24, 2003
Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparumNikhil H Gokhale, Subhash B Padhye, Simon L Croft, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin BGert-Jan Wijnant, Katrien Van Bocxlaer, Amanda Fortes Francisco, et al.
International Journal of Antimicrobial Agents|May 30, 2017
Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasisHollie Burrell-Saward, Andrew J Harris, Raul de LaFlor, et al.
Pain|May 17, 2003
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle painLois J Kehl, Darryl T Hamamoto, Paul W Wacnik, et al.
Pageof 36